Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: donpat who wrote (11898)	2/8/2019 1:26:31 PM
From: BoredMember	Read Replies (2) \| Respond to of 12873

And a CEO and successful millionaire doctor and investor who are in a position to know the truth, walked away from a multi billion dollar opportunity. Makes perfect sense.

To: donpat who wrote (11898)	2/8/2019 4:01:30 PM
From: Colavita365	Read Replies (3) \| Respond to of 12873

Anil is a scientific genius whose research on nanovircides technology has actually never been published in a peer reviewed scientific journal in 20 years of its evolution- just in his rosy press releases year after year and in a few conference posters that are not subject to peer scrutiny or a closer examination of data. A genius who has by now expended close to 90 million shareholder bucks and 14 years as a public company without even getting to a single INDfor a drug against any virus - much of the funds going to himself and his Theracour. A true genius who wangled from is Board Theracour-NNVC penalty-free agreement contracts that do not require him to even meet any milestones or timelines or any measurable metrics of competent management, and yet be rewarded time and again by the crony toadies. Yup, manipulative genius personified.